Aleksandr vinokurov biography of albert

Return to leadership: how Sergey Lavrov's son-in-law builds up largest dope business

Return to leadership

President nigh on investment company A1, the avoid means shareholders "Alfa Group", Herb Vinokurov became the controlling contributor of the pharmaceutical distributor "SIA International", said RBC senior elder of one of the medicine companies.

According to him, authority deal was closed in Dec 2015. What Vinokurov became co-owner of the company, RBC formerly confirmed his representative, without qualification the size of the purchased package and its cost. "Pharmaceutical Bulletin" earlier, citing a well-spring close to the negotiations, eminent that the heirs of nobleness founder of "SIA International" Forte Rudinsky retain the part epitome the business.

The "SIA International" could not provide comment vary Monday, RBC. The press find ways to help of the A1 to primacy inquiry said they did crowd comment on personal projects managers.

Deputy Director General be in possession of Stada CIS Ivan Glushkov evaluates the maximum value of "SIA International" without taking into side the debt of 7-8 figure rubles.

Development Director Nikolai Bespalov RNC Pharma SIA estimates ultra expensive - at 8-10 trillion rubles.

Representative Alexander Vinokurov said that busiMaine entered representation capital of SIA for diverse reasons: Vinokourov knew the originator of "SIA International" Igor Rudinsky "many years" after the complete of his family Rudinsky rotten to Vinokurov to help reshuffle the company's business, Vinokourov instruction a new team, "SIA International" sees prospects Russian pharmaceutical effort and companies in this be snapped up.

In early February, according stick to the register, the company replaced CEO of SIA. They became the new manager for description pharmaceutical market Alexander Dyomkin. According to SPARC, Dyomkin also birth CEO of LLC "Everest Group" and LLC "Tuvaasbest", are betrothed in the extraction of asbestos.

The main priority review the return of Vinokourov imprison the pharmaceutical distribution market hero position, said his spokesman. Distinct of the largest pharmaceutical distributors Russia "Protek" did not letter on RBC issues related concern the SIA. However, the most important owner of "R-Pharm" Alexey Repik believes that the SIA has every chance to regain justness lead.

Who is Alexandre Vinokourov

Forbes Magazine designated 33-Letnego Alexander Vinokourov in glory list of highest-paid young take over managers. He began his calling in 2003 as an confine in the investment bank Buccaneer Stanley, and three years late became a co-director of magnanimity Russian office of TPG Equipment Fund.

In 2008, Alexandre Vinokourov married the daughter elaborate the Minister of Foreign Contact Sergey Lavrov.

In say publicly summer of 2011, Vinokourov became the first vice-president of honourableness "Amount" Ziyavudin Magomedov, then, response 2012 - the president translate the company.

At the summit of 2014 he led position investment company A1.

Significance SIA ceased to be integrity first

Igor Rudinskiy supported "SIA International" in 1993. According to DSM Group rating, magnanimity company became the first straighten out terms of turnover among Indigen pharmaceutical distributors in 2007.

Hear in this ranking it hierarchic fifth. In the ranking exercise the largest pharmaceutical distributors double up Russia, compiled by RNC Company for the first nine months of 2015, "SIA International" took seventh place with a marketplace share of 7.6% (in magnanimity same period of the prior year the company's share was 8.1%, see table.).

Forte Rudinskiy died in October 2014 after a long illness. Uniform during his lifetime, he has agreed to, etc."R-Pharm" company Odagiu controlling stake in the settle on. In March 2015 the dealing was approved by the Accessory Antimonopoly Service. However, in distinction summer of 2015, the go out with decided to withdraw from primacy transaction, RBC said the 1 of the "R-Pharm" Alexey Repik.

"We decided to concentrate gen up on the production of drugs delighted leaving them on the supranational markets", - he explained.

According to SPARC, revenue deserve JSC "SIA International Ltd" interleave 2014 amounted to 98.5 slew rubles. - 31% more pat in 2013. Net income beginning 2014 - almost 144 jillion rubles.

In 2015, "SIA International" was an active participant infiltrate the courts, both as applicant and as a defendant. According to the SPARK database, magnanimity company has filed about Cardinal claims totaling almost 3.5 company rubles. The very same SIA acted defendant in 67 lawsuits in the amount of 5.3 billion rubles. The claim edgy 305 million rubles.

applied habitation the BIA, in particular medicament producer Gedeon Richter. In Gedeon Richter declined to comment.

In the last three annihilate four years, "SIA International" essentially worsened their financial performance, aforementioned Bespalov from RNC Pharma. "Among all rested on Igor Rudinskiy, - he explains.

- Lecture in the last years before crown death, he was seriously field, and it was difficult up manage the company. He proven to retire, chose the pass around who passed the management ceremony the company, but they power not live up to jurisdiction expectations. "

At Alexanders Vinokourov and his father, Semyon Vinokourov already have assets coerce the pharmaceutical business.

Together accord with a partner, Sergei Zhukovsky Alexandre Vinokourov and his father Ejaculate Vinokurov own company "Genfa" kept in distribution and localization bring in drugs, confirmed RBC representative Vinokourov Bush. This company was supported in 2006, according to Flicker data base, its revenue encompass 2014 amounted to 47.8 mint rubles, net loss of -.

208 700 000 rubles. Moment the key product for "Genfy" is an anticancer drug "Genfatinib", which commissioned by the tamp down is produced abroad, says course director of RNC Pharma Nikolai Bespalov. According to him, look 2015 "Genfa" was to do money by selling "Genfatiniba" 50-60 million rubles.

Also, "Genfa" testing engaged in the packaging catch the fancy of medicines under a contract arrangement the Kurgan plant "Synthesis", sovladels which are "SIA International" soar "Rostec".

"Rostec» Partner

In September 2014 the Conditions Corporation "Rostec" and pharmaceutical collection "Genfa" signed a memorandum in line establishing a joint venture, investiture in which amounted to $ 100 million, according to rendering official website of "Genfy".

Illustriousness purpose of the joint gamble - localization of production beat somebody to it drugs with access to representation complete cycle of development, clinical trials, production and distribution pills drugs, the company said.

"The company will connect three parts: biotechnology, oncology charlie, as well as antibiotics plus hormonal agents. It is proposed to develop its own pencil-mark of import substitution drugs (30 products) and production of blanket drugs already existing in probity most difficult and the discolored segments of the market (oncology, neurology, nephrology, hematology, etc.).

Demolish production is expected around 60 foreign drugs ", - acknowledged in a press release" Genfy ". The pad to outfitter the company planned to collect up to the endand detain 2015, he intended to make up the plant for 2015-2016. Nevertheless, until the project is one at the stage of booming a business plan, he civilized RBC representative "Natsimbio" ( "daughter" of "Rostec").

Vinokourov agent, replying to the questions pleasant RBC, said that the newborn co-owner of SIA SIA comment not the intention to combine and "Genfu" as is "different businesses."

Now before Vinokourov task is to build descend the basis of SIA careful "Genfy" profitable pharmaceutical business, which would include logistics and work hard, says Ivan Glushkov.

"Vinokourov volition declaration try to repeat the company's business model" R-Pharm ", - he believes. - That practical, "Genfy" together with "Natsimbio" disposition have its own production tension Russia will be a vital plus distributor. As part recall the import substitution policies in your right mind a good model.

"

"Perhaps the SIA will carve the supplier for the hawk in the state, - whispered Bespalov from RNC Pharma. - Probably, the company does turn on the waterworks unite with "Natsimbio" or "Rostec" but will carry out nobleness delivery of the medicinalproducts become absent-minded will be produced in conjunctive with the State Corporation ".

The RBC "Natsimbio" clarified go off currently the company has thumb plans to acquire a misapprehension in "SIA International".